Edition:
United States

Marrone Bio Innovations Inc (MBII.OQ)

MBII.OQ on NASDAQ Stock Exchange Capital Market

1.89USD
21 Sep 2018
Change (% chg)

$-0.09 (-4.55%)
Prev Close
$1.98
Open
$1.97
Day's High
$1.98
Day's Low
$1.89
Volume
369,778
Avg. Vol
120,497
52-wk High
$3.39
52-wk Low
$0.86

Select another date:

Thu, May 10 2018

BRIEF-Marrone Bio Innovations Q1 Revenue $4.3 Million Versus $4.2 Million

* MARRONE BIO INNOVATIONS, INC. REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-Evogene And Marrone Bio Innovations Announce Phase Advancement In Their Insect Control Collaboration

* EVOGENE AND MARRONE BIO INNOVATIONS ANNOUNCE PHASE ADVANCEMENT IN THEIR INSECT CONTROL COLLABORATION

BRIEF-Marrone Bio Innovations Appoints Kevin Hammill As New Chief Commercial Officer

* MARRONE BIO INNOVATIONS APPOINTS KEVIN HAMMILL AS NEW CHIEF COMMERCIAL OFFICER Source text for Eikon: Further company coverage:

BRIEF-Marrone Bio Innovations And Lidorr Chemicals Sign Distribution Agreement In Israel

* MARRONE BIO INNOVATIONS AND LIDORR CHEMICALS LTD. SIGN DISTRIBUTION AGREEMENT IN ISRAEL

BRIEF-Marrone Bio Innovations Announces Proposed Public Offering Of Common Stock

* MARRONE BIO INNOVATIONS, INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

BRIEF-Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders

* Marrone Bio Innovations Files Prospectus Relates To Offering Of Up To 119 Mln Shares Of Co's Common Stock By Selling Stockholders - SEC Filing Source text (https://bit.ly/2IDKFzU) Further company coverage:

BRIEF-Marrone Bio Innovations Inc Files For Non-Timely 10-K With U.S. SEC

* MARRONE BIO INNOVATIONS INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2uJc15x) Further company coverage:

BRIEF-Marrone Bio Innovations Says Q4 Revenue Rose 23.3 Pct To $3.3 Mln

* MARRONE BIO INNOVATIONS, INC. REPORTS RECORD FULL YEAR 2017 FINANCIAL RESULTS

Select another date: